Correction: Casili et al. Therapeutic Potential of BAY-117082, a Selective NLRP3 Inflammasome Inhibitor, on Metastatic Evolution in Human Oral Squamous Cell Carcinoma (OSCC). Cancers 2023, 15 , 2796...Casili G, Scuderi S, Lanza M, et al. CANCERS. 2023;15(10):2796.